NIVABUPA vs RSDFIN: Stock Comparison

NIVA BUPA HEALTH INS CO L vs RSDFINUpdated 2 Sept 26, 4:08 PM ISTNSE & company filings

NIVA BUPA HEALTH INS CO L is the larger company by market capitalisation. NIVA BUPA HEALTH INS CO L shows faster revenue growth, while RSDFIN shows a higher ROE, a higher ROCE and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

NIVABUPA leads 2; RSDFIN leads 4 of 7

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

NIVABUPARSDFIN

Valuation lens

What price are you paying?

Market CapContext only
₹14,923 Cr
₹124 Cr
P/E RatioSame reading
116.18x
P/B RatioSame reading
4x
EPSRSDFIN has the higher reading
₹1.87
₹2.37
Book ValueContext only
₹23.73
₹194.8
Dividend YieldSame reading
0%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
NIVABUPA is the larger company
₹14,923 Cr vs ₹124 Cr
EPS
RSDFIN has higher earnings per share
₹2.37 vs ₹1.87
Revenue Growth (TTM YoY)
NIVABUPA has faster revenue growth
26.8% vs 0%
EPS Growth (TTM YoY)
NIVABUPA has faster EPS growth
90.2% vs 0%
ROE
RSDFIN has a higher ROE
6.13% vs 0%
ROCE
RSDFIN has a higher ROCE
8.37% vs 0%
Net Margin
RSDFIN has a higher net margin
36.67% vs 4.34%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricNIVABUPARSDFIN
SectorFinancial Services
IndustryGeneral Insurance

Price

MetricNIVABUPARSDFIN
Live Price₹80.73₹160.46
Day Change-1.91%9.99%
Volume3.66 L39,691
52-Week High₹91.4₹160.46
52-Week Low₹67.5₹65.6
Distance from 52W High-11.67%0%

Valuation

MetricNIVABUPARSDFIN
Market Cap₹14,923 Cr₹124 Cr
P/E Ratio116.18x
P/B Ratio4x
EPS₹1.87₹2.37
Book Value₹23.73₹194.8
Dividend Yield0%0%

Growth

MetricNIVABUPARSDFIN
Revenue Growth (TTM YoY)26.8%0%
EPS Growth (TTM YoY)90.2%0%
Qtr Sales Growth-74.08%
Qtr Profit Growth-56.15%

Profitability & Leverage

Debt-to-equity is shown for reference only — it is not a like-for-like metric for banks and financials.
MetricNIVABUPARSDFIN
ROE0%6.13%
ROCE0%8.37%
Net Margin4.34%36.67%
Operating Margin49.95%
Debt to Equity0.07x0.01x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricNIVABUPARSDFIN
Promoter Holding0%74.98%
FII Holding12.09% 1.49 pp
DII Holding16.17% 0.32 pp
Public Holding16.44% 1.11 pp25.02%

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: NIVA BUPA HEALTH INS CO L and RSDFIN.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.